Concepedia

The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial

Vibeke Strand, David Jayne, Audra Horomanski, Huibin Yue, Pirow Bekker, Peter A. Merkel, Chen Au Peh, Aron Chakera, Bruce A. Cooper, Jagadeesh Kurtkoti,

The Lancet Rheumatology · 2023 · 30 citations · 26 references

DOIFull text

Open access

Concepts

References

26

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

J. Charles Jennette, Ronald J. Falk, P. A. Bacon et al. · Arthritis & Rheumatism · 2012 · 6.6K citations · Full text

, , +16

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

John H. Stone, Peter A. Merkel, Robert Spiera et al. · New England Journal of Medicine · 2010 · 2.7K citations · Full text

, , +17

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

Rachel Jones, Jan Willem Cohen Tervaert, Thomas Häuser et al. · New England Journal of Medicine · 2010 · 1.7K citations · Full text

, , +14

A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies

David Jayne, Niels Rasmussen, K. Andrássy et al. · New England Journal of Medicine · 2003 · 1.4K citations · Full text

, , +16

Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

Chetan Mukhtyar, R Lee, Denise Scott Brown et al. · Annals of the Rheumatic Diseases · 2008 · 1.2K citations

, , +14